84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證 患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19-21.
　Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(11):19-21.
點擊復(fù)制

加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證 患者骨密度的影響()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第25卷
期數(shù):
2013年11期
頁碼:
19-21
欄目:
臨床研究
出版日期:
2013-11-30

文章信息/Info

Title:
Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney
作者:
黃建華; 黃建武; 李慧輝; 李托
溫州醫(yī)科大學(xué)附屬第三醫(yī)院,浙江 瑞安 325200
Author(s):
Huang Jianhua*; Huang Jianwu; Li Huihui; LiTuo.*
The Third Affiliated Hospital of Wenzhou Medical College,Rui'an 325200,Zhejiang,China
關(guān)鍵詞:
骨質(zhì)疏松; 絕經(jīng)后 加味左歸丸 骨密度 治療; 臨床研究性
Keywords:
Osteoporosis;  postmenopausal;  JIAWEI ZUOGUI pill;  Bone density;  Therapies; investigational
摘要:
目的:觀察加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證患者骨密度的影響。方法:將92例絕經(jīng)后骨質(zhì)疏松癥肝腎不足證患者隨機分為2組,治療組53例,對照組39例。治療組采用加味左歸丸治療,對照組采用骨康膠囊治療。比較2組患者的骨密度,臨床療效和不良反應(yīng)發(fā)生情況。結(jié)果:①骨密度。治療前2組患者骨密度比較,差異無統(tǒng)計學(xué)意義(t=0.727,P=0.469),治療后2組患者的骨密度均增加[(-3.58±0.79),(-2.19±0.67),t=9.769,P=0.000;(-3.71±0.92),(-3.21±0.49),t=2.996,P=0.004],治療組增加更明顯[(1.57±0.74),(1.24±0.65),t=2.224,P=0.029]。②臨床療效。治療組臨床控制33例、顯著進步8例、進步7例、無效5例,對照組臨床控制13例、顯著進步7例、進步10例、無效9例。治療組臨床療效優(yōu)于對照組。③不良反應(yīng)發(fā)生率。治療期間治療組3例患者出現(xiàn)腹脹、1例發(fā)生口腔潰瘍,對照組2例出現(xiàn)惡心癥狀,經(jīng)對癥處理后均治愈。結(jié)論:加味左歸丸能明顯增加絕經(jīng)后骨質(zhì)疏松癥肝腎不足證患者的骨密度,是治療該病的有效手段。
Abstract:
Objective:To observe the effect of JIAWEI ZUOGUI pill on bone mineral density(BMD)in postmenopausal osteoporosis patients with deficiency of liver and kidney.Methods:Ninety-two postmenopausal osteoporosis patients with deficiency of liver and kidney were randomly divided into 2 groups,53 cases in treatment group,while 39 cases in control group.Patients in treatment group were treated with JIAWEI ZUOGUI pill,while patients in control group were treated with GUKANG capsule.The BMD,clinical effects and complications were compared between the 2 groups.Results:There was no statistical difference in BMD between the 2 groups before the treatment(t=0.727,P=0.469),while the BMD increased in both of the 2 groups after the treatment(-3.58+/-0.79 vs -2.19+/-0.67,t=9.769,P=0.000; -3.71+/-0.92 vs -3.21+/-0.49,t=2.996,P=0.004),and the BMD increased more significantly in the treatment group(1.57+/-0.74 vs 1.24+/-0.65,t=2.224,P=0.029).Thirty-three patients obtained an excellent clinical curative effects,8 good,7 fair,and 5 poor in treatment group,while 13 cases obtained an excellent clinical curative effects,7 good,10 fair,and 9 poor in control group.Three patients with flatulence,2 patients with oral ulcer were found in the treatment group,while 2 patients with nausea symptom were found in the control group,which were all cured after treatment.Conclusion:The BMD of postmenopausal osteoporosis patients with deficiency of liver and kidney can be obviously increased by JIAWEI ZUOGUI pill,so it is the effective therapy to this disease.

參考文獻/References:

[1] 王博,李玉雄.抗骨疏膠囊治療原發(fā)性骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2010,22(5):21-22.
[2] 許超,肖魯偉,童培建.骨質(zhì)疏松癥的中醫(yī)辨證分型客觀化研究[J].中醫(yī)正骨,2010,22(2):27-30.
[3] 蔣天驕.中藥左歸丸聯(lián)合維D、磷酸氫鈣片治療骨質(zhì)疏松癥療效觀察[J].臨床合理用藥,2011,4(4A):54
[4] 鞠大宏,張春英,王安明,等.左歸丸對去卵巢所致大鼠骨質(zhì)疏松癥的治療作用[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2001,7(3):17-18.
[5] 劉忠厚,楊定桌,朱漢民,等.中國人原發(fā)性骨質(zhì)疏松癥診斷標(biāo)準(zhǔn)(試行)[J].中國骨質(zhì)疏松雜志,1999,5(1):1-3.
[6] 鄭筱萸,任德權(quán),曹文莊,等.中藥新藥臨床研究指導(dǎo)原則(試行)[S].北京:中國醫(yī)藥科技出版社,2002:356-360.
[7] 楊少輝,吳素芳,許紅霞.骨質(zhì)疏松防治藥物的研究進展[J].中國骨質(zhì)疏松雜志,2010,16(10):786-790.
[8] 呂海波,任艷玲,王瑩,等.左歸丸防治去卵巢大鼠骨質(zhì)疏松癥的實驗研究[J]. 中國骨質(zhì)疏松雜志,20l1,16(11):847-850.
[9] 相湘.熟地抗疲勞作用的實驗研究[J].中國現(xiàn)代藥物應(yīng)用,2011,5(5):118-119.
[10] 王志超,李志毅.鹿角膠丸對骨質(zhì)疏松模型大鼠影響的實驗研究[J].中醫(yī)正骨,2003,15(11):16-17.
[11] 李全,王立新,盧堅.二仙提取液對去卵巢大鼠脛骨中段皮質(zhì)骨形態(tài)計量學(xué)的影響[J].湖南中醫(yī)藥大學(xué)學(xué)報,2007,27(3):25-28.

相似文獻/References:

[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的 胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
　HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):7.
[3]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
　LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):12.
[4]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng) 在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
　Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):27.
[6]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
　Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(11):20.
[7]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
　Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
　Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的 相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
　CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(11):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
　XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(11):3.

備注/Memo

備注/Memo:
2012-03-15收稿 2013-02-10修回
更新日期/Last Update: 2013-11-30